Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study
Titel:
Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study
Auteur:
Pires da Silva, Ines Ahmed, Tasnia Reijers, Irene L M Weppler, Alison M Betof Warner, Allison Patrinely, James Randall Serra-Bellver, Patricio Allayous, Clara Mangana, Joanna Nguyen, Khang Zimmer, Lisa Trojaniello, Claudia Stout, Dan Lyle, Megan Klein, Oliver Gerard, Camille L Michielin, Olivier Haydon, Andrew Ascierto, Paolo A Carlino, Matteo S Lebbe, Celeste Lorigan, Paul Johnson, Douglas B Sandhu, Shahneen Lo, Serigne N Blank, Christian U Menzies, Alexander M Long, Georgina V